Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures.

Neuropsychiatr Dis Treat · 2011 · PMC3140293 · PMID 21792307

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not quite statistically significantno p-value reported

25 Five percent of patients in the treated group were seizure-free during the maintenance phase compared with 1% in the placebo group, a difference that was not quite statistically significant.

also in 341 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.